Corporate Overview

Electromed (NYSE American: ELMD) is a profitable and growing medical device company that develops, manufactures, markets and sells innovative High Frequency Chest Wall Oscillation (HFCWO) airway clearance products, primarily for use in the home setting. Our flagship product, the SmartVest® Airway Clearance System, is a differentiated device designed for patient comfort and ease of use. We believe the domestic market for HFCWO devices is largely untapped, with fewer than 20% of the approximately 600,000 patients diagnosed with bronchiectasis in the US currently using this non-invasive therapy.

We employ an efficient direct-to-patient and provider model, through which we obtain patient referrals directly from clinicians, and take the administrative burden off patients and providers by managing the entire insurance claim, product delivery, and training processes on their behalf. In this way, we “Take the Pressure Off” of patients and providers, improving the quality of life for patients with compromised pulmonary function, reduce healthcare utilization and, in turn, enhance value for our shareholders.

An older SmartVest patient performs his HFCWO therapy as he's completing a crossword puzzle.
An older SmartVest patient performs his HFCWO therapy as he's completing a crossword puzzle.

NYSE American | ELMD

    Investor Resources

    Press Releases